SAN DIEGO --(BUSINESS WIRE)--Jul. 31, 2019-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2019 . Second Quarter 2019 Highlights: Revenue grew 39% versus the same quarter of the prior year to $336.4 million U.S.

SAN DIEGO --(BUSINESS WIRE)--Jul. 2, 2019-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2019 financial results after market close on Wednesday, July 31, 2019 . Management will hold a conference call to review the company's second quarter 2019 performance

SAN DIEGO --(BUSINESS WIRE)--Jun. 6, 2019-- DexCom, Inc. (NASDAQ:DXCM) and Companion Medical, Inc. today announced a collaboration to enable a direct exchange of CGM data from Dexcom with insulin data from InPen™ into both companies’ software applications.

SAN DIEGO --(BUSINESS WIRE)--May 22, 2019-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Steven Pacelli , Executive Vice President, Strategy and Corporate Development, will present an update on the company

SAN DIEGO --(BUSINESS WIRE)--May 1, 2019-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2019 . First Quarter 2019 Highlights: Revenue grew 52% versus the same quarter of the prior year to $280.5 million U.S.

SAN DIEGO --(BUSINESS WIRE)--Apr. 3, 2019-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2019 financial results after market close on Wednesday, May 1, 2019 . Management will hold a conference call to review the company's first quarter 2019 performance

SAN DIEGO --(BUSINESS WIRE)--Feb. 25, 2019-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Steven Pacelli , Executive Vice President, Strategy and Corporate Development, will present an update on the

VANCOUVER , Feb. 22, 2019 /CNW/ - Dexcom , Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), today announced that the company has received Health Canada approval for its next generation Dexcom G6 CGM System for people with diabetes ages two years and up.

The Company also Announces Expansion and Reorganization of its Customer Support Functions SAN DIEGO --(BUSINESS WIRE)--Feb. 21, 2019-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2018 .

SAN DIEGO --(BUSINESS WIRE)--Jan. 24, 2019-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2018 financial results after market close on Thursday, February 21, 2019 . Management will hold a conference call to review the company's fourth quarter